Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent.

Schroeder, Patricia E; Hofland, Kenneth Francis; Jensen, Peter Buhl; Sehested, Maxwell; Langer, Seppo W; Hasinoff, Brian B

Schroeder, Patricia E; Hofland, Kenneth Francis; Jensen, Peter Buhl; Sehested, Maxwell; Langer, Seppo W; Hasinoff, Brian B.

Affiliation

Schroeder PE; Faculty of Pharmacy, University of Manitoba, 50 Sifton Road, Winnipeg, Manitoba, Canada R3T 2N2.

Cancer Chemother Pharmacol ; 53(1): 91-3, 2004 Jan.

Article in En | MEDLINE | ID: mdl-14574459

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/blood; Brain Neoplasms/blood; Brain Neoplasms/secondary; Carcinoma, Small Cell/blood; Carcinoma, Small Cell/metabolism; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Area Under Curve; Brain Neoplasms/drug therapy; Carcinoma, Small Cell/drug therapy; Catheters, Indwelling; Chromatography, High Pressure Liquid; Etoposide/administration & dosage; Etoposide/blood; Humans; Infusions, Intravenous; Lung Neoplasms/blood; Lung Neoplasms/drug therapy; Lung Neoplasms/pathology; Razoxane/administration & dosage; Razoxane/blood

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Small Cell Type of study: Prognostic_studies Limits: Adult / Humans Language: En Journal: Cancer Chemother Pharmacol Year: 2004 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links